Exploiting the Epigenome to Control Cancer-Promoting Gene-Expression Programs.

Abstract excerpt

The epigenome is a key determinant of transcriptional output. Perturbations within the epigenome are thought to be a key feature of many, perhaps all cancers, and it is now clear that epigenetic changes are instrumental in cancer development. The inherent reversibility of these changes makes them attractive targets for therapeutic manipulation, and a number of small molecules targeting chromatin-based mechanisms...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Chromatin
• Share to Clinical Trials as Topic
• Share to Epigenomics